Xbiotech Stock Today
| XBIT Stock | USD 8.07 0.11 1.34% |
Performance16 of 100
| Odds Of DistressLess than 30
|
XBiotech is selling for under 8.07 as of the 24th of April 2024; that is -1.34 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 7.75. XBiotech has about a 30 percent probability of financial distress in the next few years of operation but had a somewhat solid performance during the last 90 days. Equity ratings for XBiotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 15th of April 2015 | Category Healthcare | Classification Health Care |
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company was incorporated in 2005 and is headquartered in Austin, Texas. Xbiotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 30.45 M outstanding shares of which 604.5 K shares are at this time shorted by private and institutional investors with about 9.64 trading days to cover. More on XBiotech
Moving together with XBiotech Stock
| 0.7 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.76 | ELEV | Elevation Oncology Earnings Call Next Week | PairCorr |
| 0.71 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.73 | CGC | Canopy Growth Corp Trending | PairCorr |
Moving against XBiotech Stock
| 0.81 | GILD | Gilead Sciences Earnings Call Tomorrow | PairCorr |
| 0.7 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.5 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
XBiotech Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. XBiotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding XBiotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | John Simard | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Cancer Fighters (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators obtained from XBiotech's historical financial statements, XBiotech is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of XBiotech is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
XBiotech (XBIT) is traded on NASDAQ Exchange in USA. It is located in 5217 Winnebago Lane, Austin, TX, United States, 78744 and employs 82 people. XBiotech is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 250.31 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate XBiotech's market, we take the total number of its shares issued and multiply it by XBiotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. XBiotech conducts business under Biotechnology sector and is part of Health Care industry. The entity has 30.45 M outstanding shares of which 604.5 K shares are at this time shorted by private and institutional investors with about 9.64 trading days to cover.
XBiotech currently holds about 225.79 M in cash with (18.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.42.
Check XBiotech Probability Of Bankruptcy
Ownership AllocationXBiotech owns a total of 30.45 Million outstanding shares. XBiotech owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check XBiotech Ownership Details
XBiotech Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of XBiotech jumping above the current price in 90 days from now is about 18.88%. The XBiotech probability density function shows the probability of XBiotech stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days XBiotech has a beta of -1.4865. This entails as returns on its benchmark rise, returns on holding XBiotech are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, XBiotech is expected to outperform its benchmark. Moreover, xBiotech has an alpha of 1.1259, implying that it can generate a 1.13 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of XBiotech to move above the current price in 90 days from now is about 18.88 (This XBiotech probability density function shows the probability of XBiotech Stock to fall within a particular range of prices over 90 days) .
XBiotech Stock Institutional Holders
Institutional Holdings refers to the ownership stake in XBiotech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of XBiotech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing XBiotech's value.| Instituion | Recorded On | Shares | |
| Man Group Plc | 2023-12-31 | 58.4 K | |
| State Street Corporation | 2023-12-31 | 56.5 K | |
| Qube Research & Technologies | 2023-12-31 | 56.5 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 55.7 K | |
| Susquehanna International Group, Llp | 2023-12-31 | 37.4 K | |
| Two Sigma Investments Llc | 2023-12-31 | 25.4 K | |
| Two Sigma Advisers, Llc | 2023-12-31 | 24 K | |
| Fmr Inc | 2023-12-31 | 20 K | |
| Squarepoint Ops Llc | 2023-12-31 | 18.9 K | |
| Vanguard Group Inc | 2023-12-31 | 881.5 K | |
| Millennium Management Llc | 2023-12-31 | 795.7 K |
XBiotech Historical Income Statement
XBiotech Income Statement is one of the three primary financial statements used for reporting XBiotech's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of XBiotech revenue and expense. XBiotech Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, XBiotech's Depreciation And Amortization is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 7.9 M in 2024, whereas Operating Income is likely to drop (39.4 M) in 2024. View More FundamentalsXBiotech Stock Against Markets
Picking the right benchmark for XBiotech stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in XBiotech stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for XBiotech is critical whether you are bullish or bearish towards XBiotech at a given time. Please also check how XBiotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in XBiotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
XBiotech Corporate Directors
XBiotech corporate directors refer to members of a XBiotech board of directors. The board of directors generally takes responsibility for the XBiotech's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of XBiotech's board members must vote for the resolution. The XBiotech board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Peter Libby | Director | Profile | |
| JanPaul Waldin | Independent Director | Profile | |
| Daniel Vasella | Lead Independent Director | Profile | |
| Michael Stecher | Medical Director | Profile |
How to buy XBiotech Stock?
Before investing in XBiotech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in XBiotech. To buy XBiotech stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of XBiotech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase XBiotech stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located XBiotech stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased XBiotech stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as XBiotech, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy XBiotech Stock please use our How to Invest in XBiotech guide.
Already Invested in XBiotech?
The danger of trading XBiotech is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of XBiotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than XBiotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile XBiotech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether XBiotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if XBiotech Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Xbiotech Stock. Highlighted below are key reports to facilitate an investment decision about Xbiotech Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XBiotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy XBiotech Stock please use our How to Invest in XBiotech guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for XBiotech Stock analysis
When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is XBiotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XBiotech. If investors know XBiotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XBiotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Revenue Per Share 0.01 | Quarterly Revenue Growth (0.93) | Return On Assets (0.1) | Return On Equity (0.11) |
The market value of XBiotech is measured differently than its book value, which is the value of XBiotech that is recorded on the company's balance sheet. Investors also form their own opinion of XBiotech's value that differs from its market value or its book value, called intrinsic value, which is XBiotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XBiotech's market value can be influenced by many factors that don't directly affect XBiotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XBiotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if XBiotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XBiotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.